Early Psychosis Programs
Who is eligible for EDAPT?
- Males and females, ages 12-40
- Insured or private pay
- Experiencing the symptoms of early psychosis, including:
- Onset of psychotic symptoms in the past year
- Subthreshold symptoms of psychosis
- Recent deterioration in youth with a parent/sibling with a psychotic disorder
If you or someone you know is interested in clinical services through EDAPT or would like to learn more about our clinic, please contact:
Jane DuBe, LCSW
If you are experiencing symptoms but are unsure whether our clinical services are right for you, please take this 21-question screening survey:
Click HERE to take the screening survey
Our recovery based treatment approach provides services for 2 years focusing on 1) reducing and managing symptoms and distress and 2) improving individuals' ability to achieve success in independent roles.
Comprehensive Psychiatric Assessment
State-of-the-art clinical assessment tools are used to evaluate each client to determine the appropriate diagnosis in order to guide treatment. Assessments of psychosocial functioning also determine areas where targeted treatment is needed.
Regular and frequent appointments with a psychiatrist, tailored to control and alleviate symptoms with the fewest amount of side effects.
Each client has a clinical case manager who helps to identify the client's unique needs and recovery goals, which will be used to develop a treatment plan that encourages the client to build upon their strengths and take an active role in treatment decisions.
Individual Psychoeducation and Support Groups
Weekly groups for clients are designed to provide support and improve understanding of the illness, develop stress and symptom management techniques, and enhance communication and problem solving skills. Specific groups include:
- Advanced Social Skills group
- Substance Abuse Management group
- Family Member Support group
Our Clinical Team
|Stefano Pallanti, MD, Ph.D.|
Stefano Pallanti is full Professor of Psychiatry at UC Davis, Associate Professor of Psychiatry at the University of Florence in Italy and Visiting Professor at the Albert Einstein College of Medicine, New York. He is also Adjunct Associate Professor at the Icahn School of Medicine at Mount Sinai, New York, and there he served as the Founder and Director of the Center of Excellence for OCD, Impulsive and Behavioural Addiction. He is particularly interested in subjective experience of prodromal psychosis including fearful bodily experience, misophonia, self and the other anomalous experiences, and psychosensory symptoms. He is an internationally recognized expert in use of rTMS for the treatment of hallucinations and mixed mood disorders, and for the improvement of cognitive function. He is a Fellow Member and the Scientific Board of the European College of Neuropsychopharmacology (ECNP).
|Jane DuBe is a Licensed Clinical Social Worker and a graduate of the Masters of Social Welfare program at the University of California, Berkeley. She has past experience in crisis services, dual diagnosis treatment, forensic mental health, and inpatient mental health services. In the SacEDAPT Clinic, Jane conducts diagnostic assessments, provides case management services, as well as coordinating individual and family groups.|